| Record ID | marc_records_scriblio_net/part15.dat:204882448:1482 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part15.dat:204882448:1482?format=raw |
LEADER: 01482cam 2200337 a 4500
001 82002433 //r962
003 DLC
005 19961023113513.4
008 820301s1982 ne a b 101 0 eng
010 $a 82002433 //r962
020 $a0444804013
040 $aDLC$cDLC$dDLC
050 00 $aRC271.I45$bN48 1982
060 $aWI HU444WF v. 3$aQZ 267 N5325
082 00 $a616.99/4061$219
245 00 $aNew immunomodulating agents and biological response modifiers /$cedited by B. Serrou and C. Rosenfeld ; guest editors, J. Wybran and G. Meyer.
260 0 $aAmsterdam ;$aNew York :$bElsevier Biomedical Press ;$aNew York :$bSole distributors for the U.S.A. and Canada, Elsevier Science Pub. Co.,$c1982.
300 $axiii, 164 p. :$bill. ;$c25 cm.
440 0 $aHuman cancer immunology ;$vv. 3
500 $a"Contains the lectures presented on September 29, 1980 at the Erasme Hospital, University of Brussels by the Tumor Immunology Project Group (TIPG)"--Foreword.
504 $aIncludes bibliographical references and index.
650 0 $aImmunotherapy$xCongresses.
650 0 $aBiological response modifiers.
650 0 $aCancer$xChemotherapy$xCongresses.
650 0 $aImmune response$xRegulation$xCongresses.
650 2 $aNeoplasms$xDrug therapy.
650 2 $aNeoplasms$xImmunology.
650 2 $aAdjuvants, Immunologic$xTherapeutic use.
650 2 $aAntineoplastic agents$xTherapeutic use.
700 10 $aSerrou, B.$q(Bernard)
700 10 $aRosenfeld, C.$q(Claude)